Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs

Harley O’Connor Mount, Nicole M. Revie, Robert T. Todd, Kaitlin Anstett, Cathy Collins, Michael Costanzo, Charles Boone, Nicole Robbins, Anna Selmecki, Leah E. Cowen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.

Original languageEnglish (US)
Article numbere1007319
JournalPLoS Genetics
Volume14
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

azoles
Azoles
antifungal agents
resistance mechanisms
genetic techniques and protocols
drug
gene
Pharmaceutical Preparations
ergosterol
chromosome
Candida albicans
mutation
Ergosterol
genome
Chromosomes, Human, Pair 3
Genes
chromosomes
protein
genes
GTP Phosphohydrolase Activators

All Science Journal Classification (ASJC) codes

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Cite this

Mount, H. OC., Revie, N. M., Todd, R. T., Anstett, K., Collins, C., Costanzo, M., ... Cowen, L. E. (2018). Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs. PLoS Genetics, 14(4), [e1007319]. https://doi.org/10.1371/journal.pgen.1007319

Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs. / Mount, Harley O’Connor; Revie, Nicole M.; Todd, Robert T.; Anstett, Kaitlin; Collins, Cathy; Costanzo, Michael; Boone, Charles; Robbins, Nicole; Selmecki, Anna; Cowen, Leah E.

In: PLoS Genetics, Vol. 14, No. 4, e1007319, 01.04.2018.

Research output: Contribution to journalArticle

Mount, HOC, Revie, NM, Todd, RT, Anstett, K, Collins, C, Costanzo, M, Boone, C, Robbins, N, Selmecki, A & Cowen, LE 2018, 'Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs', PLoS Genetics, vol. 14, no. 4, e1007319. https://doi.org/10.1371/journal.pgen.1007319
Mount, Harley O’Connor ; Revie, Nicole M. ; Todd, Robert T. ; Anstett, Kaitlin ; Collins, Cathy ; Costanzo, Michael ; Boone, Charles ; Robbins, Nicole ; Selmecki, Anna ; Cowen, Leah E. / Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs. In: PLoS Genetics. 2018 ; Vol. 14, No. 4.
@article{bd9f74f71af94b21969c5783e29a50fc,
title = "Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs",
abstract = "Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.",
author = "Mount, {Harley O’Connor} and Revie, {Nicole M.} and Todd, {Robert T.} and Kaitlin Anstett and Cathy Collins and Michael Costanzo and Charles Boone and Nicole Robbins and Anna Selmecki and Cowen, {Leah E.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1371/journal.pgen.1007319",
language = "English (US)",
volume = "14",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "4",

}

TY - JOUR

T1 - Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs

AU - Mount, Harley O’Connor

AU - Revie, Nicole M.

AU - Todd, Robert T.

AU - Anstett, Kaitlin

AU - Collins, Cathy

AU - Costanzo, Michael

AU - Boone, Charles

AU - Robbins, Nicole

AU - Selmecki, Anna

AU - Cowen, Leah E.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.

AB - Invasive fungal infections caused by the pathogen Candida albicans have transitioned from a rare curiosity to a major cause of human mortality. This is in part due to the emergence of resistance to the limited number of antifungals available to treat fungal infections. Azoles function by targeting the biosynthesis of ergosterol, a key component of the fungal cell membrane. Loss-of-function mutations in the ergosterol biosynthetic gene ERG3 mitigate azole toxicity and enable resistance that depends upon fungal stress responses. Here, we performed a genome-wide synthetic genetic array screen in Saccharomyces cerevisiae to map ERG3 genetic interactors and uncover novel circuitry important for azole resistance. We identified nine genes that enabled erg3-mediated azole resistance in the model yeast and found that only two of these genes had a conserved impact on resistance in C. albicans. Further, we screened a C. albicans homozygous deletion mutant library and identified 13 genes for which deletion enhances azole susceptibility. Two of the genes, RGD1 and PEP8, were also important for azole resistance acquired by diverse mechanisms. We discovered that loss of function of retrograde transport protein Pep8 overwhelms the functional capacity of the stress response regulator calcineurin, thereby abrogating azole resistance. To identify the mechanism through which the GTPase activator protein Rgd1 enables azole resistance, we selected for mutations that restore resistance in strains lacking Rgd1. Whole genome sequencing uncovered parallel adaptive mechanisms involving amplification of both chromosome 7 and a large segment of chromosome 3. Overexpression of a transporter gene on the right portion of chromosome 3, NPR2, was sufficient to enable azole resistance in the absence of Rgd1. Thus, we establish a novel mechanism of adaptation to drug-induced stress, define genetic circuitry underpinning azole resistance, and illustrate divergence in resistance circuitry over evolutionary time.

UR - http://www.scopus.com/inward/record.url?scp=85046438331&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046438331&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1007319

DO - 10.1371/journal.pgen.1007319

M3 - Article

VL - 14

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 4

M1 - e1007319

ER -